InsiderClue
← All stocks

Xencor Inc

XNCR Net selling
CIK 0001326732 #2044 in the set updated 18 Sep 2026
Bought (120 mo)
$12.49M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$107.39M
$511.60K on a plan · $25.86M straight out of an exercise
Sold at will
$81.02M
99 of 148 sales
Net
−$94.90M
−$68.53M against sales at will

By person

21 insiders · 194 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
STAFFORD JOHN S III
10% owner
$12.49M (31)
$70.17M (26)
−$57.68M
11,061,556
14.88%
$144.46M
−11.3%
Desjarlais John R
SR. VICE PRESIDENT & CSO
—
$9.60M (21) scheduled
−$9.60M
263,831
0.3548%
$3.45M
+712.9%
Dahiyat Bassil I
PRESIDENT & CEO
—
$8.49M (18) scheduled
−$8.49M
546,316
0.7348%
$7.13M
+340.1%
Baracchini Edgardo Jr
Chief Business Officer
—
$5.24M (14) scheduled
−$5.24M
207
0.0003%
$2.70K
0.0%
Kuch John J
SR. VICE PRESIDENT & CFO
—
$4.14M (12) scheduled
−$4.14M
121,070
0.1628%
$1.58M
+95.1%
Foster Paul A
Chief Medical Officer
—
$3.87M (7) scheduled
−$3.87M
4,952
0.0067%
$64.67K
0.0%
Ronin Capital, LLC entity
10% owner
—
$2.27M (2)
−$2.27M
5,012,430
6.74%
$65.46M
−1.5%
CARTER BRUCE L A
Director
—
$739.50K (5)
−$739.50K
48,578
0.0653%
$634.43K
+636.0%
Yang Allen
SR. VICE PRESIDENT & CMO
—
$595.95K (6)
−$595.95K
73,364
0.0987%
$958.13K
+4,597%
Montgomery Alan Bruce
Director
—
$519.01K (5) scheduled
−$519.01K
25,849
0.0348%
$337.59K
—
GUSTAFSON KURT A
Director
—
$471.20K (4) scheduled
−$471.20K
25,011
0.0336%
$326.64K
—
Eckert Celia
SVP, GENERAL COUNSEL
—
$431.22K (12)
−$431.22K
76,918
0.1034%
$1.00M
+1,205%
Valente Nancy
EVP, Chief Development Officer
—
$197.66K (3)
−$197.66K
49,169
0.0661%
$642.15K
+2,171%
GORMAN KEVIN CHARLES
Director
$1.01K (1)
$176.80K (3) scheduled
−$175.78K
21,680
0.0292%
$283.14K
—
Feigal Ellen
Director
—
$168.73K (3) scheduled
−$168.73K
12,340
0.0166%
$161.16K
—
RANIERI RICHARD J
Director
—
$146.74K (3) scheduled
−$146.74K
24,011
0.0323%
$313.58K
—
Cornelissen Bart Jan
SR. VICE PRESIDENT & CFO
—
$101.53K (3)
−$101.53K
75,898
0.1021%
$991.23K
+3,710%
ROSA-BJORKESON DAGMAR
Director
—
$51.76K (1)
−$51.76K
8,490
0.0114%
$110.88K
—
Klencke Barbara
Director
—
—
—
29,974
0.0403%
$391.46K
—
SIMPSON TODD E
Director
—
—
—
23,988
0.0323%
$313.28K
—
Deshaies Raymond Joseph
Director
—
—
—
10,302
0.0139%
$134.54K
—

Individual transactions

39
Insider
Date
Role
Action
Shares
Price
Amount
Dahiyat Bassil I
19 Dec 2025
PRESIDENT & CEO
Sold after exercise
114,377
$15.71
$1.80M
Desjarlais John R
19 Dec 2025
SR. VICE PRESIDENT & CSO
Sold after exercise
73,367
$15.72
$1.15M
Montgomery Alan Bruce
4 Dec 2024
Director
Sold after exercise
1,421
$27.03
$38.41K
Montgomery Alan Bruce
2 Dec 2024
Director
Sold after exercise
13,301
$27.03
$359.52K
Dahiyat Bassil I
21 Nov 2024
PRESIDENT & CEO
Sold after exercise
49,278
$24.07
$1.19M
Dahiyat Bassil I
13 Nov 2024
PRESIDENT & CEO
Sold after exercise
3,366
$24.02
$80.84K
Desjarlais John R
11 Nov 2024
SR. VICE PRESIDENT & CSO
Sold after exercise
68,684
$23.48
$1.61M
Desjarlais John R
9 Jul 2024
SR. VICE PRESIDENT & CSO
Sold after exercise
36,329
$18.32
$665.51K
GUSTAFSON KURT A
6 Mar 2024
Director
Sold after exercise
14,000
$23.18
$324.45K
Desjarlais John R
13 Feb 2024
SR. VICE PRESIDENT & CSO
Sold after exercise
54,108
$19.38
$1.05M
Dahiyat Bassil I
29 Dec 2023
PRESIDENT & CEO
Sold after exercise
45,000
$20.93
$941.67K
Dahiyat Bassil I
21 Jun 2023
PRESIDENT & CEO
Sold after exercise
33,497
$26.19
$877.29K
Kuch John J
1 Mar 2021
SR. VICE PRESIDENT & CFO
Sold after exercise
15,065
$48.90
$736.67K
Kuch John J
21 Aug 2019
Sr. Vice President & CFO
Sold after exercise
40,000
$41.27
$1.65M
Foster Paul A
17 Sep 2018
Chief Medical Officer
Sold after exercise
40,000
$46.03
$1.84M
Foster Paul A
17 Aug 2018
Chief Medical Officer
Sold after exercise
3,659
$40.10
$146.73K
Foster Paul A
16 Aug 2018
Chief Medical Officer
Sold after exercise
20,739
$41.10
$852.37K
Foster Paul A
15 Aug 2018
Chief Medical Officer
Sold after exercise
106
$41.10
$4.36K
Foster Paul A
14 Aug 2018
Chief Medical Officer
Sold after exercise
15,496
$41.11
$636.98K
Baracchini Edgardo Jr
13 Aug 2018
Chief Business Officer
Sold after exercise
12,734
$40.35
$513.87K
Desjarlais John R
9 Aug 2018
Sr. V.P., Research & CSO
Sold after exercise
20,133
$40.61
$817.63K
Baracchini Edgardo Jr
9 Aug 2018
Chief Business Officer
Sold after exercise
8,283
$40.35
$334.20K
Dahiyat Bassil I
15 Jun 2018
President and CEO
Sold after exercise
50,000
$40.51
$2.03M
Kuch John J
13 Jun 2018
Sr. Vice President & CFO
Sold after exercise
25,000
$41.64
$1.04M
Baracchini Edgardo Jr
15 Mar 2018
Chief Business Officer
Sold after exercise
40,000
$30.89
$1.24M
Baracchini Edgardo Jr
5 Mar 2018
Chief Business Officer
Sold after exercise
10,000
$29.58
$295.84K
Baracchini Edgardo Jr
2 Mar 2018
Chief Business Officer
Sold after exercise
10,000
$29.60
$295.97K
Baracchini Edgardo Jr
27 Feb 2018
Chief Business Officer
Sold after exercise
20,000
$29.64
$592.85K
Foster Paul A
22 Feb 2018
Chief Medical Officer
Sold after exercise
10,000
$26.03
$260.30K
Baracchini Edgardo Jr
22 Feb 2018
Chief Business Officer
Sold after exercise
8,069
$26.00
$209.79K
Foster Paul A
16 Feb 2018
Chief Medical Officer
Sold after exercise
5,000
$25.01
$125.05K
Baracchini Edgardo Jr
2 May 2017
Chief Business Officer
Sold after exercise
750
$26.07
$19.55K
Baracchini Edgardo Jr
1 May 2017
Chief Business Officer
Sold after exercise
9,818
$26.01
$255.37K
Baracchini Edgardo Jr
27 Apr 2017
Chief Business Officer
Sold after exercise
904
$26.04
$23.54K
Kuch John J
16 Mar 2017
Vice President, Finance
Sold after exercise
15,000
$24.42
$366.28K
Baracchini Edgardo Jr
8 Mar 2017
Chief Business Officer
Sold after exercise
1,821
$25.00
$45.53K
Desjarlais John R
5 Dec 2016
Sr. V.P., Research & CSO
Sold after exercise
45,000
$26.57
$1.20M
Baracchini Edgardo Jr
28 Sep 2016
Chief Business Officer
Sold after exercise
2,954
$25.78
$76.15K
Baracchini Edgardo Jr
28 Sep 2016
Chief Business Officer
Sold after exercise
7,046
$25.17
$177.33K
Show all 194 transactions →

What was left out

Form 4 filings counted 243
Amendments (4/A) skipped 9
Filings about a different issuer 2
Unreadable filings 0
Joint filings 22
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 39
Sales at will 99
Transactions with no price 0
Shares from compensation/vesting 2,561,915
Sales filed before the plan box existed 67
History held since 1 Sep 2016